应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VYNE VYNE Therapeutics Inc.
休市中 08-23 16:00:00 EDT
1.87
-0.01
-0.53%
盘后
1.81
-0.06
-3.21%
18:29 EDT
最高
1.89
最低
1.81
成交量
2.24万
今开
1.89
昨收
1.88
日振幅
4.26%
总市值
2,758万
流通市值
1,883万
总股本
1,475万
成交额
4.19万
换手率
0.22%
流通股本
1,007万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Vyne Therapeutics Inc.2024财年第二财季实现净利润-9.40百万美元,同比增加6.37%
自选股智能写手 · 08-18
Vyne Therapeutics Inc.2024财年第二财季实现净利润-9.40百万美元,同比增加6.37%
Vyne Therapeutics Inc 预计每股亏损 19 美分 - 财报前瞻
Reuters · 08-10
Vyne Therapeutics Inc 预计每股亏损 19 美分 - 财报前瞻
Vyne Therapeutics Inc.盘中异动 早盘大幅跳水5.77%
自选股智能写手 · 08-02
Vyne Therapeutics Inc.盘中异动 早盘大幅跳水5.77%
Vyne Therapeutics Inc.盘中异动 早盘股价大跌5.16%报2.02美元
自选股智能写手 · 07-22
Vyne Therapeutics Inc.盘中异动 早盘股价大跌5.16%报2.02美元
Vyne Therapeutics Inc.盘中异动 早盘快速上涨6.36%报1.84美元
自选股智能写手 · 06-25
Vyne Therapeutics Inc.盘中异动 早盘快速上涨6.36%报1.84美元
HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价由5.
智通财经 · 06-05
HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价由5.
Vyne Therapeutics Inc.盘中异动 快速下跌5.80%报2.44美元
自选股智能写手 · 05-30
Vyne Therapeutics Inc.盘中异动 快速下跌5.80%报2.44美元
Vyne Therapeutics Inc.盘中异动 股价大涨6.89%
自选股智能写手 · 05-13
Vyne Therapeutics Inc.盘中异动 股价大涨6.89%
Vyne Therapeutics Inc.盘中异动 下午盘股价大涨5.17%
自选股智能写手 · 05-08
Vyne Therapeutics Inc.盘中异动 下午盘股价大涨5.17%
Vyne Therapeutics Inc 预计每股亏损 24 美分 - 财报前瞻
Reuters · 05-07
Vyne Therapeutics Inc 预计每股亏损 24 美分 - 财报前瞻
HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价5.75美元。
智通财经 · 05-06
HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价5.75美元。
Vyne Therapeutics Inc.盘中异动 股价大跌7.61%
自选股智能写手 · 04-11
Vyne Therapeutics Inc.盘中异动 股价大跌7.61%
Vyne Therapeutics Inc.盘中异动 早盘快速下挫5.39%报2.91美元
自选股智能写手 · 04-02
Vyne Therapeutics Inc.盘中异动 早盘快速下挫5.39%报2.91美元
Vyne Therapeutics Inc.盘中异动 大幅上涨5.24%报2.60美元
自选股智能写手 · 03-26
Vyne Therapeutics Inc.盘中异动 大幅上涨5.24%报2.60美元
Vyne Therapeutics Inc.盘中异动 下午盘快速上涨5.05%报2.29美元
自选股智能写手 · 03-22
Vyne Therapeutics Inc.盘中异动 下午盘快速上涨5.05%报2.29美元
Vyne Therapeutics Inc.盘中异动 大幅上涨5.19%
自选股智能写手 · 03-19
Vyne Therapeutics Inc.盘中异动 大幅上涨5.19%
Vyne Therapeutics Inc.盘中异动 快速上涨5.78%报2.38美元
自选股智能写手 · 03-07
Vyne Therapeutics Inc.盘中异动 快速上涨5.78%报2.38美元
Vyne Therapeutics Inc.盘中异动 临近收盘股价大跌5.38%报2.11美元
自选股智能写手 · 03-02
Vyne Therapeutics Inc.盘中异动 临近收盘股价大跌5.38%报2.11美元
HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价5.
智通财经 · 03-01
HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价5.
Vyne Therapeutics Inc盘中异动 快速上涨6.19%报2.40美元
自选股智能写手 · 02-26
Vyne Therapeutics Inc盘中异动 快速上涨6.19%报2.40美元
暂无数据
公司概况
公司名称:
VYNE Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
VYNE Therapeutics Inc.成立于2011年10月,是特拉华州的一家公司,名称为Tigercat Pharma,Inc.。该公司是一家专业制药公司,致力于开发和商业化专有疗法,以满足皮肤病学未满足的需求。
发行价格:
--
{"stockData":{"symbol":"VYNE","market":"US","secType":"STK","nameCN":"VYNE Therapeutics Inc.","latestPrice":1.87,"timestamp":1724443200000,"preClose":1.88,"halted":0,"volume":22429,"hourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.87,"latestTime":"18:29 EDT","volume":521,"amount":943.11,"timestamp":1724452149285},"delay":0,"floatShares":10068532,"shares":14749397,"eps":-0.954681,"marketStatus":"休市中","marketStatusCode":7,"change":-0.01,"latestTime":"08-23 16:00:00 EDT","open":1.89,"high":1.89,"low":1.81,"amount":41913.4715362,"amplitude":0.042553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.954681,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1516856400000,"adjPreClose":1.88,"postHourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.87,"latestTime":"18:29 EDT","volume":521,"amount":943.11,"timestamp":1724452149285},"volumeRatio":0.9320174558305171,"impliedVol":3.8705,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/VYNE/tweets","defaultTab":"tweets","newsList":[{"id":"2460736680","title":"Vyne Therapeutics Inc.2024财年第二财季实现净利润-9.40百万美元,同比增加6.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736680","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736680?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910667,"startTime":"0","endTime":"0","summary":"8月18日,Vyne Therapeutics Inc.公布财报,公告显示公司2024财年第二财季净利润为-9.40百万美元,同比增加6.37%;其中营业收入为198000.00美元,同比增加46.67%,每股基本收益为-0.22美元。从资产负债表来看,Vyne Therapeutics Inc.总负债11.78百万美元,其中短期债务120000.00美元,资产负债比为7.36,流动比率为7.14。机构评级:截至2024年8月18日,当前有3家机构对Vyne Therapeutics Inc.目标价做出预测,其中目标均价为5.58美元,其中最低目标价为5.00美元,最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006559f3407c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006559f3407c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ"],"gpt_icon":0},{"id":"2458512036","title":"Vyne Therapeutics Inc 预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458512036","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458512036?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:07","pubTimestamp":1723226833,"startTime":"0","endTime":"0","summary":" * Vyne Therapeutics Inc 预计将在8月12日公布截至2024年6月30日的业绩() 时显示季度收入下降 * 根据LSEG的数据,一位分析师预计,这家总部位于新泽西州布里奇沃特的公司的营收将从去年同期的13.5万美元下降至11万美元,降幅为18.5%。* LSEG 分析师对 Vyne Therapeutics Inc 的平均预期是每股亏损 19 美分。* 华尔街对 Vyne Therapeutics Inc 的 12 个月目标价中位数为 5.75 美元,高于其上一次收盘价 1.77 美元。8月9日 - 本摘要于北京时间 8 月 9 日 18:07 机器生成。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE","LENZ"],"gpt_icon":0},{"id":"2456284605","title":"Vyne Therapeutics Inc.盘中异动 早盘大幅跳水5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456284605","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456284605?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:49","pubTimestamp":1722606556,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时49分,Vyne Therapeutics Inc.股票出现异动,股价大幅下跌5.77%。截至发稿,该股报1.72美元/股,成交量1.0435万股,换手率0.07%,振幅2.75%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.90%。其相关个股中,Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大,Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1314.92%、505.64%、41.43%,振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.,振幅分别为54.19%、49.18%、37.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214916af95a700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214916af95a700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE","BK4139","LENZ"],"gpt_icon":0},{"id":"2453572795","title":"Vyne Therapeutics Inc.盘中异动 早盘股价大跌5.16%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453572795","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453572795?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:59","pubTimestamp":1721656759,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时59分,Vyne Therapeutics Inc.股票出现波动,股价快速下跌5.16%。截至发稿,该股报2.02美元/股,成交量2324股,换手率0.02%,振幅3.85%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.23%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222159209681ee79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222159209681ee79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","VYNE","BK4139"],"gpt_icon":0},{"id":"2446902841","title":"Vyne Therapeutics Inc.盘中异动 早盘快速上涨6.36%报1.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446902841","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446902841?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:31","pubTimestamp":1719322275,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时31分,Vyne Therapeutics Inc.股票出现异动,股价大幅上涨6.36%。截至发稿,该股报1.84美元/股,成交量3883股,换手率0.03%,振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大,Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为84.65%、77.75%、56.52%,振幅较大的相关个股有Glycomimetics, Inc.、Lipella Pharmaceuticals Inc.、Senti Biosciences, Inc.,振幅分别为12.94%、12.48%、7.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406252131159f640dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406252131159f640dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VYNE","LENZ","BK4007"],"gpt_icon":0},{"id":"2441208604","title":"HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价由5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441208604","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441208604?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:20","pubTimestamp":1717600853,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","VYNE","LENZ","BK4007"],"gpt_icon":0},{"id":"2439045115","title":"Vyne Therapeutics Inc.盘中异动 快速下跌5.80%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439045115","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439045115?lang=zh_cn&edition=full","pubTime":"2024-05-30 02:30","pubTimestamp":1717007424,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日02时30分,Vyne Therapeutics Inc.股票出现异动,股价大幅跳水5.80%。截至发稿,该股报2.44美元/股,成交量5.5954万股,换手率0.39%,振幅5.21%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.01%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530023024aef25a99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530023024aef25a99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VYNE","BK4007"],"gpt_icon":0},{"id":"2435372481","title":"Vyne Therapeutics Inc.盘中异动 股价大涨6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435372481","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435372481?lang=zh_cn&edition=full","pubTime":"2024-05-13 23:45","pubTimestamp":1715615102,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日23时45分,Vyne Therapeutics Inc.股票出现波动,股价大幅拉升6.89%。截至发稿,该股报2.85美元/股,成交量1.0026万股,换手率0.07%,振幅4.12%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.16%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513234502792763d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513234502792763d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VYNE","BK4007","BK4139"],"gpt_icon":0},{"id":"2433738771","title":"Vyne Therapeutics Inc.盘中异动 下午盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433738771","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433738771?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:19","pubTimestamp":1715102353,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时19分,Vyne Therapeutics Inc.股票出现波动,股价快速上涨5.17%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.03%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。该信息摘要如下:HC Wainwright & Co.:重申VYNE Therapeutics评级,由买入调整至买入评级, 目标价5.75美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801191479264f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801191479264f85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE","BK4139","LENZ"],"gpt_icon":0},{"id":"2433799482","title":"Vyne Therapeutics Inc 预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433799482","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433799482?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:01","pubTimestamp":1715079710,"startTime":"0","endTime":"0","summary":" * Vyne Therapeutics Inc 预计将在5月9日公布截至0001年1月1日的业绩报告(估计),季度收入将有所增长。* LSEG 分析师对 Vyne Therapeutics Inc 的平均预期是每股亏损 24 美分。* 华尔街对 Vyne Therapeutics Inc 的 12 个月目标价中位数为 5.75 美元,高于其最新收盘价 2.71 美元。5月7日 - 本摘要于北京时间 5 月 7 日 11:01 机器生成。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VYNE"],"gpt_icon":0},{"id":"2433745408","title":"HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价5.75美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433745408","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433745408?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:55","pubTimestamp":1715007355,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价5.75美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062256018ae192a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062256018ae192a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VYNE","LENZ"],"gpt_icon":0},{"id":"2426447885","title":"Vyne Therapeutics Inc.盘中异动 股价大跌7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426447885","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426447885?lang=zh_cn&edition=full","pubTime":"2024-04-11 03:41","pubTimestamp":1712778118,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日03时41分,Vyne Therapeutics Inc.股票出现波动,股价快速跳水7.61%。截至发稿,该股报2.55美元/股,成交量5.1016万股,换手率0.36%,振幅5.07%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.89%。其相关个股中,Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Alpine Immune Sciences, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.较为活跃,换手率分别为2390.46%、105.62%、95.88%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Orgenesis Inc.、Nutriband Inc C/Wts ,振幅分别为87.61%、78.35%、52.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411034159861e4baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411034159861e4baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","VYNE"],"gpt_icon":0},{"id":"2424163043","title":"Vyne Therapeutics Inc.盘中异动 早盘快速下挫5.39%报2.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424163043","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424163043?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:37","pubTimestamp":1712065060,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时37分,Vyne Therapeutics Inc.股票出现异动,股价快速跳水5.39%。截至发稿,该股报2.91美元/股,成交量1574股,换手率0.01%,振幅0.00%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.33%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022137417a50b616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022137417a50b616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","VYNE"],"gpt_icon":0},{"id":"2422822616","title":"Vyne Therapeutics Inc.盘中异动 大幅上涨5.24%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422822616","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422822616?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:50","pubTimestamp":1711461030,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时50分,Vyne Therapeutics Inc.股票出现波动,股价大幅拉升5.24%。截至发稿,该股报2.60美元/股,成交量1.1239万股,换手率0.08%,振幅8.06%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.29%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326215031861e1418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326215031861e1418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","VYNE"],"gpt_icon":0},{"id":"2421078658","title":"Vyne Therapeutics Inc.盘中异动 下午盘快速上涨5.05%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421078658","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2421078658?lang=zh_cn&edition=full","pubTime":"2024-03-22 02:33","pubTimestamp":1711045996,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日02时33分,Vyne Therapeutics Inc.股票出现波动,股价大幅拉升5.05%。截至发稿,该股报2.29美元/股,成交量2.8288万股,换手率0.20%,振幅6.33%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.04%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322023316861e02c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322023316861e02c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2420275275","title":"Vyne Therapeutics Inc.盘中异动 大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420275275","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420275275?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:34","pubTimestamp":1710858867,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时34分,Vyne Therapeutics Inc.股票出现异动,股价急速拉升5.19%。截至发稿,该股报2.02美元/股,成交量3461股,换手率0.02%,振幅5.99%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922342787e7a178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922342787e7a178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2417247233","title":"Vyne Therapeutics Inc.盘中异动 快速上涨5.78%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417247233","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2417247233?lang=zh_cn&edition=full","pubTime":"2024-03-07 05:00","pubTimestamp":1709758821,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日05时00分,Vyne Therapeutics Inc.股票出现波动,股价快速上涨5.78%。截至发稿,该股报2.38美元/股,成交量9.4395万股,换手率0.67%,振幅6.67%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.29%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307050022861dbe44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307050022861dbe44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2416679120","title":"Vyne Therapeutics Inc.盘中异动 临近收盘股价大跌5.38%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416679120","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416679120?lang=zh_cn&edition=full","pubTime":"2024-03-02 04:43","pubTimestamp":1709325803,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日04时43分,Vyne Therapeutics Inc.股票出现波动,股价大幅跳水5.38%。截至发稿,该股报2.11美元/股,成交量7.962万股,换手率0.57%,振幅5.83%。Vyne Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为2.64%。Vyne Therapeutics Inc.公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030204432387e7552d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030204432387e7552d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2416039425","title":"HC Wainwright & Co.:重申VYNE Therapeutics(VYNE.US)评级,由买入调整至买入评级, 目标价5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2416039425","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416039425?lang=zh_cn&edition=full","pubTime":"2024-03-01 04:05","pubTimestamp":1709237135,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2414836928","title":"Vyne Therapeutics Inc盘中异动 快速上涨6.19%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414836928","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2414836928?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:21","pubTimestamp":1708960904,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时21分,Vyne Therapeutics Inc股票出现波动,股价急速拉升6.19%。Vyne Therapeutics Inc股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Zyversa Therapeutics Inc、Krystal Biotech Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Zyversa Therapeutics Inc、Lixte Biotechnology Holdings Inc、Ocean Biomedical Inc较为活跃,换手率分别为1340.15%、61.67%、56.17%,振幅较大的相关个股有Zyversa Therapeutics Inc、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ocean Biomedical Inc,振幅分别为144.82%、62.88%、52.23%。Vyne Therapeutics Inc公司简介:VYNE Therapeutics Inc 是一家生物制药公司,专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623214487e732c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623214487e732c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","VYNE","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vynetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.065},{"period":"3month","weight":-0.2752},{"period":"6month","weight":-0.1726},{"period":"1year","weight":-0.5579},{"period":"ytd","weight":-0.1974}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VYNE Therapeutics Inc.成立于2011年10月,是特拉华州的一家公司,名称为Tigercat Pharma,Inc.。该公司是一家专业制药公司,致力于开发和商业化专有疗法,以满足皮肤病学未满足的需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.103241},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.000108},{"month":3,"riseRate":0.428571,"avgChangeRate":0.048397},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.184881},{"month":5,"riseRate":0.571429,"avgChangeRate":0.038029},{"month":6,"riseRate":0,"avgChangeRate":-0.163623},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.064684},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.076567},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.043905},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.070084},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067878},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.145707}],"exchange":"NASDAQ","name":"VYNE Therapeutics Inc.","nameEN":"VYNE Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VYNE Therapeutics Inc.,VYNE,VYNE Therapeutics Inc.股票,VYNE Therapeutics Inc.股票老虎,VYNE Therapeutics Inc.股票老虎国际,VYNE Therapeutics Inc.行情,VYNE Therapeutics Inc.股票行情,VYNE Therapeutics Inc.股价,VYNE Therapeutics Inc.股市,VYNE Therapeutics Inc.股票价格,VYNE Therapeutics Inc.股票交易,VYNE Therapeutics Inc.股票购买,VYNE Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}